192 related articles for article (PubMed ID: 38784173)
1. Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study.
Choi J; Lee SR; Choi EK; Lee KY; Ahn HJ; Kwon S; Kim B; Han KD; Oh S; Lip GYH
Front Cardiovasc Med; 2024; 11():1372505. PubMed ID: 38784173
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
Wen X; Otoo MN; Tang J; Brothers T; Ward KE; Asal N; Meador KJ
JAMA Neurol; 2024 Jun; ():. PubMed ID: 38884986
[TBL] [Abstract][Full Text] [Related]
3. Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.
Foch C; Allignol A; Hostalek U; Boutmy E; Hohenberger T
Int J Clin Pract; 2022; 2022():6124559. PubMed ID: 35989866
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
[TBL] [Abstract][Full Text] [Related]
7. Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).
Hsieh MS; How CK; Hsieh VC; Chen PC
Shock; 2020 Apr; 53(4):407-415. PubMed ID: 31135703
[TBL] [Abstract][Full Text] [Related]
8. Association of Long-term Use of Antihypertensive Medications With Late Outcomes Among Patients With Aortic Dissection.
Chen SW; Chan YH; Lin CP; Wu VC; Cheng YT; Chen DY; Chang SH; Hung KC; Chu PH; Chou AH
JAMA Netw Open; 2021 Mar; 4(3):e210469. PubMed ID: 33656527
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
10. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
11. Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation.
Liu Z; Bian N; Wu S; Cao Y; Su Y; Li W; Li H; Lan X; Jiang C; Fan Y; Guo J; Chen D
Front Cardiovasc Med; 2023; 10():1191539. PubMed ID: 37424921
[TBL] [Abstract][Full Text] [Related]
12. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.
Morales DR; Conover MM; You SC; Pratt N; Kostka K; Duarte-Salles T; Fernández-Bertolín S; Aragón M; DuVall SL; Lynch K; Falconer T; van Bochove K; Sung C; Matheny ME; Lambert CG; Nyberg F; Alshammari TM; Williams AE; Park RW; Weaver J; Sena AG; Schuemie MJ; Rijnbeek PR; Williams RD; Lane JCE; Prats-Uribe A; Zhang L; Areia C; Krumholz HM; Prieto-Alhambra D; Ryan PB; Hripcsak G; Suchard MA
Lancet Digit Health; 2021 Feb; 3(2):e98-e114. PubMed ID: 33342753
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis.
Mukete BN; Cassidy M; Ferdinand KC; Le Jemtel TH
Am J Cardiovasc Drugs; 2015 Aug; 15(4):243-57. PubMed ID: 26055616
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
18. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
[TBL] [Abstract][Full Text] [Related]
19. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
Reding KW; Aragaki AK; Cheng RK; Barac A; Wassertheil-Smoller S; Chubak J; Limacher MC; Hundley WG; D'Agostino R; Vitolins MZ; Brasky TM; Habel LA; Chow EJ; Jackson RD; Chen C; Morgenroth A; Barrington WE; Banegas M; Barnhart M; Chlebowski RT
Oncologist; 2020 Aug; 25(8):712-721. PubMed ID: 32250503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
